Replies to post #61076 on $heff's $tation of $tocks & $olid DD

[$heff]

NAVB..$2.33 Back near the CRL price on Sept 10th. This has sold off since the expected class II response from the FDA & the April PDUFA date.


Message in reply to Oct 31st message:

NAVB..$2.80 Nice to see the resubmission on the NDA. Thx for posting that link.
http://finance.yahoo.com/news/navidea-biopharmaceuticals-resubmits-drug-application-132200128.html